Skip to content

Combination of Water Immersion and Carbon Dioxide Insufflation for Minimal Sedation Colonoscopy

Combination of Water Immersion and Carbon Dioxide Insufflation for Minimal Sedation Colonoscopy - a Prospective, Randomized, Single-center Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01440543
Acronym
Water/CO2
Enrollment
420
Registered
2011-09-26
Start date
2011-01-31
Completion date
2011-09-30
Last updated
2013-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Keywords

colonoscopy, water immersion, CO2 insufflation, patients referred for diagnostic outpatient colonoscopy, (screening, surveillance, symptoms), patient discomfort associated with diagnostic colonoscopy

Brief summary

Water immersion insertion and carbon dioxide (CO2)instead of room air insufflation as alternative colonoscopy techniques have been documented to decrease patient discomfort during and after the procedure. This prospective, randomized, single-center trial was designed to evaluate whether the combination of water immersion during insertion and CO2 insufflation during withdrawal (Water/CO2)for minimal sedation colonoscopy (2 mg of midazolam i.v.)is superior to the other colonoscopy methods (Water/Air, CO2/CO2, Air/Air).

Interventions

PROCEDUREWater immersion insertion AND CO2 insufflation

* room temperature water infused by water pump into the colon just to facilitate scope insertion * CO2 insufflation by CO2 insufflation system during colonoscope withdrawal and mucosal inspection

PROCEDUREWater immersion insertion

* room temperature water infused by water pump into the colon just to facilitate scope insertion * standard room air insufflation during colonoscope withdrawal and mucosal inspection

\- CO2 insufflation by CO2 insufflation system during both colonoscope insertion and withdrawal

Sponsors

Vitkovice Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* men and women older than 18 years referred for diagnostic outpatient colonoscopy * provided written consent

Exclusion criteria

* history of colorectal surgery * known diagnosis of inflammatory bowel disease * chronic benzodiazepine use * refusal of minimal sedation

Design outcomes

Primary

MeasureTime frameDescription
Success Rate of Minimal Sedation Colonoscopysix monthsSuccessful minimal sedation colonoscopy using assigned technique was defined as reaching the caecum without switch to another insertion method and / or without additional sedation beyond the initial administration of 2 mg of midazolam.

Secondary

MeasureTime frameDescription
Patient Comfort During the Procedure and During First 24 Hours After Proceduresix monthsComfort was assessed using a 18-point questionnaire form based on 0-6 continuous scale (0 = best, 6 = worst)- abdominal pain during, 30 minutes, 3, 12 and 24 hours after the procedure, bloating duringm 30 minutes, 3, 12 and 24 hours after the procedure, flatus during, 30 minutes, 3, 12 and 24 hours after the procedure, impact on patient´s daily activities during first 24 hours after the procedure, willingnes to repeat the colonoscopy and overall satisfaction with the procedure

Countries

Czechia

Participant flow

Recruitment details

* recruitment process between January and June 2011 * outpatients referred to our endoscopy unit for diagnostic colonoscopy

Pre-assignment details

* a total of 548 patients were assessed for eligibility * a total of 420 patients were randomized after exclusion of 128 subjects because of not fulfilled inclusion criteria * a total of 404 patients were analyzed after exclusion of 16 subjects (poor bowel preparation, IBD, argon plasmacoagulation, endoscopic resection or malignant obstruction)

Participants by arm

ArmCount
Water/Air
Water immersion during colonoscope insertion and air insufflation during colonoscope withdrawal
106
CO2/CO2
CO2 insufflation during both colonoscope insertion and withdrawal
105
Water/CO2
water immersion during colonoscope insertion and CO2 insufflation during colonoscope withdrawal
102
Air/Air
room air insufflation during both colonoscope insertion and withdrawal
107
Total420

Baseline characteristics

CharacteristicCO2/CO2Water/CO2Water/AirAir/AirTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
45 Participants48 Participants51 Participants49 Participants193 Participants
Age, Categorical
Between 18 and 65 years
60 Participants54 Participants55 Participants58 Participants227 Participants
Age Continuous59.4 years
STANDARD_DEVIATION 14.5
58.2 years
STANDARD_DEVIATION 13.4
60.1 years
STANDARD_DEVIATION 13.9
58.7 years
STANDARD_DEVIATION 13.8
59.2 years
STANDARD_DEVIATION 14.1
Region of Enrollment
Czech Republic
105 participants102 participants106 participants107 participants420 participants
Sex: Female, Male
Female
52 Participants49 Participants50 Participants51 Participants202 Participants
Sex: Female, Male
Male
53 Participants53 Participants56 Participants56 Participants218 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 00 / 00 / 00 / 0
serious
Total, serious adverse events
0 / 00 / 00 / 00 / 0

Outcome results

Primary

Success Rate of Minimal Sedation Colonoscopy

Successful minimal sedation colonoscopy using assigned technique was defined as reaching the caecum without switch to another insertion method and / or without additional sedation beyond the initial administration of 2 mg of midazolam.

Time frame: six months

Primary

Success Rate of Minimal Sedation Colonoscopy

A succesful colonoscopy using assigned technique was defined as reaching the caecum without switching to another insertion method and without additional sedation beyond the initial 2 mg of midazolam. Any time the further insertion of the scope was not possible, the patient reported pain level \> 3 using a 7-point Likert scale \[7\] (0 = no pain, 6 = intolerable pain) or demanded additional sedation, the endoscopist preferentially switched to the other insertion technique. Enhanced sedation was used in case the other technique had not been successful.

Time frame: 6 months

Population: Statistical power was calculated for the primary endpoint. A sample size of 145 subjects per insertion arm was calculated using two-tailed α = 0,05, β = 0,05, assuming that 80% versus 60% success rate in the water (Water/CO2 and Water/Air) and gas (CO2/CO2 and Air/Air) insertion arms would have been clinically relevant.

ArmMeasureValue (NUMBER)
CO2/CO2Success Rate of Minimal Sedation Colonoscopy82.4 percentage of all participants
Water/AirSuccess Rate of Minimal Sedation Colonoscopy97 percentage of all participants
Water/CO2Success Rate of Minimal Sedation Colonoscopy97 percentage of all participants
Air/AirSuccess Rate of Minimal Sedation Colonoscopy84.2 percentage of all participants
Secondary

Patient Comfort During the Procedure and During First 24 Hours After Procedure

Comfort was assessed using a 18-point questionnaire form based on 0-6 continuous scale (0 = best, 6 = worst)- abdominal pain during, 30 minutes, 3, 12 and 24 hours after the procedure, bloating duringm 30 minutes, 3, 12 and 24 hours after the procedure, flatus during, 30 minutes, 3, 12 and 24 hours after the procedure, impact on patient´s daily activities during first 24 hours after the procedure, willingnes to repeat the colonoscopy and overall satisfaction with the procedure

Time frame: six months

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026